Official Journal Health Science of Prince of Songkla University

  • Home
  • Search
  • Current
  • Archives
  • Announcements
  • Guide for Authors
  • Publication Ethics
  • Editorial Board
  • Submit
  • About
  • Contact
  • Online-first Articles
  • EVENTS
  • Review Process
Home > Vol 42, No 4 (2024) > Viriyaadhammaa

Diarylheptanoid 7-(3,4-Dihydroxyphenyl)-5- Hydroxy-1-Phenyl- (1E)-1-Heptene from Curcuma Comosa Roxb. Inhibits Nucleophosmin Localization and Induces Apoptosis in KG-1a Leukemic Stem Cells

Natsima Viriyaadhammaa, Suwit Duangmano, Pawaret Panyajai, Khin Khin Gyi, Singkome Tima, Sawitree Chiampanichayakul, Siriporn Okonogi, Pornngarm Dejkriengkraikul, Jeffrey Krise, Aroonchai Saiai, Songyot Anuchapreeda

Abstract

Objective: This study aimed to investigate the effect of the diarylheptanoid 7-(3,4-dihydroxyphenyl)-5- hydroxy-1-phenyl-(1E)-1-heptene (DDHPH) from the rhizome of Curcuma comosa Roxb. on nucleophosmin (NPM) protein localization followed by induced cell death in KG-1a leukemic stem cells.
Material and Methods: DDHPH was purified by column chromatography and characterized by nuclear magnetic resonance (NMR). Localization of NPM was determined by a confocal microscopy. Induction of cell death was determined by flow cytometry and Western blotting.
Results: A previous study showed that NPM directly interacted with p53 and activates p53 function. In this study, DDHPH was found to modify the translocation of NPM and enhance both p53 and cleaved caspase-3 expression. These proteins were found to control cell cycle progression and cell apoptosis induction.
Conclusion: This study demonstrated that DDHPH is a novel compound which induces cell death through NPM localization.

 Keywords

apoptosis; Curcuma comosa; cytotoxicity; diarylheptanoids; nucleophosmin; Zingiberaceae

 Full Text:

PDF

References

Boonsrangsom T. Genetic diversity of ‘Wan Chak Motluk’ (Curcuma comosa Roxb.) in Thailand using morphological characteristics and random amplification of polymorphic DNA (RAPD) markers. S Afr J Bot 2020;130:224-30.

Nakamura S, Qu Y, Xu F, Matsuda H, Yoshikawa M. Structures of new monoterpenes from Thai herbal medicine Curcuma comosa. Chem Pharm Bull 2008;56:1604-6.

Thongon N, Boonmuen N, Suksen K, Wichit P, Chairoungdua A, Tuchinda P, et al. Selective estrogen receptor modulator (SERM)-like activities of diarylheptanoid, a phytoestrogen from Curcuma comosa, in breast cancer cells, pre-osteoblast cells, and rat uterine tissues. J Agric Food Chem 2017;65:3490-6.

Suksamrarn A, Ponglikitmongkol M, Wongkrajang K, Chindaduang A, Kittidanairak S, Jankam A, et al. Diarylheptanoids, new phytoestrogens from the rhizomes of Curcuma comosa: isolation, chemical modification and estrogenic activity evaluation. Bioorg Med Chem 2008;16:6891-902.

Winuthayanon W, Piyachaturawat P, Suksamrarn A, Ponglikitmongkol M, Arao Y, Hewitt SC, et al. Diarylheptanoid phytoestrogens isolated from the medicinal plant Curcuma comosa: biologic actions in vitro and in vivo indicate estrogen receptor–dependent mechanisms. Environ Health Perspect 2009;117:1155-61.

Suksen K, Charaslertrangsi T, Noonin C, Jariyawat S, Devakul Na Ayutthaya W, Suksamrarn A, et al. Protective effect of diarylheptanoids from Curcuma comosa on primary rat hepatocytes against t-butyl hydroperoxide-induced toxicity. Pharm Biol 2016;54:853-62.

Viriyaadhammaa N, Saiai A, Neimkhum W, Nirachonkul W, Chaiyana W, Chiampanichayakul S, et al. Cytotoxic and antiproliferative effects of diarylheptanoids isolated from Curcuma comosa Rhizomes on leukaemic cells. Molecules 2020;25:5476. doi: 10.3390/molecules25225476.

Jariyawat S, Thammapratip T, Suksen K, Wanitchakool P, Nateewattana J, Chairoungdua A, et al. Induction of apoptosis in murine leukemia by diarylheptanoids from Curcuma comosa Roxb. Cell Biol Toxicol 2011;27:413-23.

Sperr W, Hauswirth A, Florian S, Öhler L, Geissler K, Valent P. Human leukaemic stem cells: a novel target of therapy. Eur J Clin Invest 2004;34:31-40.

Okuwaki M, Tsujimoto M, Nagata K. The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Mol Biol Cell 2002;13:2016-30.

Box JK, Paquet N, Adams MN, Boucher D, Bolderson E, O’Byrne KJ, et al. Nucleophosmin: from structure and function to disease development. BMC Mol Biol 2016;17:1-12.

Lim MJ, Wang XW. Nucleophosmin and human cancer. Cancer Detect Prev 2006;30:481-90.

Di Matteo A, Franceschini M, Chiarella S, Rocchio S, Travaglini-Allocatelli C, Federici L. Molecules that target nucleophosmin for cancer treatment: an update. Oncotarget 2016;7:44821.

Li J, Sejas DP, Rani R, Koretsky T, Bagby GC, Pang Q. Nucleophosmin regulates cell cycle progression and stress response in hematopoietic stem/progenitor cells. J Biol Chem 2006;281:16536-45.

Lo SJ, Fan LC, Tsai YF, Lin KY, Huang HL, Wang TH, et al. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells. Hepatology 2013;57:1893-905.

Colombo E, Marine J-C, Danovi D, Falini B, Pelicci PG. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 2002;4:529-33.

Termini D, Den Hartogh DJ, Jaglanian A, Tsiani E. Curcumin against prostate cancer: current evidence. Biomolecules 2020;10:1536.

Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 2002;512:334-40.

Shaw PH. The role of p53 in cell cycle regulation. Pathol Res Pract 1996;192:669-75.

Viriyaadhammaa N, Duangmano S, Saiai A, Tungjai M, Dejkriengkraikul P, Tima S, et al. A novel drug modulator diarylheptanoid (trans-1,7-Diphenyl-5-hydroxy-1-heptene) from Curcuma comosa Rhizomes for P-glycoprotein function and apoptosis induction in K652/ADR leukemic cells. Int J Mol Sci 2022;23:8989. doi: 10.3390/ijms23168989.

Tebbi CK. Etiology of acute leukemia: a review. Cancers (Basel) 2021;13:2256.

Popa MA, Wallace KJ, Brunello A, Extermann M, Balducci L. Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy. J Geriatr Oncol 2014;5:307-14.

Vagace JM, de la Maya MD, Caceres-Marzal C, de Murillo SG, Gervasini G. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma. Crit Rev Oncol Hematol 2012;84:274-86.

Brodská B, Šašinková M, Kuželová K. Nucleophosmin in leukemia: consequences of anchor loss. Int J Biochem Cell Biol 2019;111:52-62.

Karimi Dermani F, Gholamzadeh Khoei S, Afshar S, Amini R. The potential role of nucleophosmin (NPM1) in the development of cancer. J Cell Physiol 2021;236:7832-52.

Ozaki T, Nakagawara A. Role of p53 in cell death and human cancers. Cancers (Basel) 2011;3:994-1013.

Kerr L, Birse-Archbold J-L, Short D, McGregor A, Heron I, Macdonald D, et al. Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene 2007;26:2554-62.

Ye K. Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis. Cancer Biol Ther 2005;4:918-23.

Wang Z, Gall JM, Bonegio R, Havasi A, Illanes K, Schwartz JH, et al. Nucleophosmin, a critical Bax cofactor in ischemiainduced cell death. Mol Cell Biol 2013;33:1916-24.

DOI: http://dx.doi.org/10.31584/jhsmr.20241034

Refbacks

  • There are currently no refbacks.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SUBMIT A PAPER

JHSMR accepts online submission through

AHR-iCON 2024

Journal Metrics


2020
Acceptance rate: 52%
2021
Acceptance rate: 27.8%
2022 (March)
Acceptance rate: 15.6%
2023 (June)
Acceptance rate: 23.6%


Submission to final decision
74 days

Acceptance to publication
40 days

SCImago Journal & Country Rank

About The Authors

Natsima Viriyaadhammaa
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Suwit Duangmano
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Pawaret Panyajai
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Khin Khin Gyi
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Singkome Tima
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200, Thailand. Cancer Research Unit of Associated Medical Sciences (AMS CRU), Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200, Thailand. Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Sawitree Chiampanichayakul
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200, Thailand. Cancer Research Unit of Associated Medical Sciences (AMS CRU), Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200, Thailand. Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Siriporn Okonogi
Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Mueang, Chiang Mai 50200, Thailand. Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Pornngarm Dejkriengkraikul
Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Jeffrey Krise
Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas 66045,
United States

Aroonchai Saiai
Department of Chemistry, Faculty of Science, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Songyot Anuchapreeda
Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200, Thailand. Cancer Research Unit of Associated Medical Sciences (AMS CRU), Faculty of Associated Medical Sciences, Chiang Mai University, Mueang, Chiang Mai 50200, Thailand. Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Mueang, Chiang Mai 50200,
Thailand

Article Tools
Abstract
Print this article
Indexing metadata
How to cite item
Email this article (Login required)
Email the author (Login required)

Supported by

 

JHSMR now Indexed in



Scopus logo.svg






Image result for crossref





PSUMJ Homepage

Keywords COVID-19 SARS-CoV-2 Thailand Vietnam anxiety children computed tomography depression diabetes diabetes mellitus elderly hypertension knowledge mental health mortality prevalence quality of life risk factors stroke treatment validity
Journal Content

Browse
  • By Issue
  • By Author
  • By Title
Font Size
Make font size smaller Make font size default Make font size larger

Open Journal Systems